ARSArs Technica·1wHealth
score-0.60
FDA Advises Patients of Small and Mixed Risk of Vision Loss from GLP-1 Drugs
Original
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
“Frames a regulatory warning about potential side effects with an emphasis on vision loss risk, evoking concern.”